Mark Douglas Yandell

University Of Utah

$10,527,606

Attributed

$19,940,270

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2008–25

$2M$1.5M$1M$500K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$19,940,270 · 12

By mechanism

R01$7,961,528 · 5

U01$6,586,746 · 3

R44$2,603,208 · 2

UM1$2,004,050 · 1

RC2$784,738 · 1

Top collaborators

Most similar at University Of Utah

Same institution · by research overlap

Christopher P. Hill$27,112,994
William L. Carroll$23,653,738
Mary C. Beckerle$16,693,203
Carl S. Thummel$15,049,537
Gregory A. Voth$20,545,848

Others in their field

Top investigators on “Genes”

David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
Richard A Gibbs · Baylor College Of Medicine$338,750,128
Barton F Haynes · Duke University$304,076,400
Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
Richard K. Wilson · Washington University$195,881,965

Research focus

GenesBaseGenomicsInnovationGenome SequencingGenomeUtahDesignResourcesDatabasesComputer SoftwarePhenotypeCollaborationsPathway InteractionsResearch PersonnelDiagnosticData SetSamplingScientistMethodologyBioinformaticsVariantOntologyGenome-Wide

Grant awards (44)

Empowering Interoperable Genomics-Enabled Learning Health Systems at Scale$636,787

U01 · FY2025 · HG

Empowering Interoperable Genomics-Enabled Learning Health Systems at Scale$636,462

U01 · FY2024 · HG

Bridging the Gap between Genomics and Clinical Outcomes in CHD$410,988

U01 · FY2024 · HL

Bridging the Gap between Genomics and Clinical Outcomes in CHD$419,375

U01 · FY2023 · HL

Bridging the Gap between Genomics and Clinical Outcomes in CHD$419,375

U01 · FY2022 · HL

Life history-guided drug discovery from venomous marine snails$297,375

R01 · FY2022 · GM · contact PI

Bridging the Gap between Genomics and Clinical Outcomes in CHD$419,375

U01 · FY2021 · HL

Life history-guided drug discovery from venomous marine snails$297,375

R01 · FY2021 · GM · contact PI

Bridging the Gap between Genomics and Clinical Outcomes in CHD$419,375

U01 · FY2020 · HL

Life history-guided drug discovery from venomous marine snails$297,375

R01 · FY2020 · GM · contact PI

Integrating Genomic and Clinical Approaches to Sudden Death in the Young$806,163

U01 · FY2019 · HL

Bridging the Gap between Genomics and Clinical Outcomes in CHD$400,810

UM1 · FY2019 · HL

Life history-guided drug discovery from venomous marine snails$297,375

R01 · FY2019 · GM · contact PI

Integrating Genomic and Clinical Approaches to Sudden Death in the Young$806,282

U01 · FY2018 · HL

Bridging the Gap between Genomics and Clinical Outcomes in CHD$400,810

UM1 · FY2018 · HL

Integrating Genomic and Clinical Approaches to Sudden Death in the Young$806,282

U01 · FY2017 · HL

Bridging the Gap between Genomics and Clinical Outcomes in CHD$400,810

UM1 · FY2017 · HL

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding$117,526

R01 · FY2017 · GM · contact PI

Integrating Genomic and Clinical Approaches to Sudden Death in the Young$806,282

U01 · FY2016 · HL

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding$461,842

R01 · FY2016 · GM · contact PI

Bridging the Gap between Genomics and Clinical Outcomes in CHD$400,810

UM1 · FY2016 · HL

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding$524,124

R01 · FY2015 · GM · contact PI

Bridging the Gap between Genomics and Clinical Outcomes in CHD$400,810

UM1 · FY2015 · HL

Genomics-based Venom Studies Using the Cone Snail C. Bullatus$283,100

R01 · FY2015 · GM · contact PI

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding$542,481

R01 · FY2014 · GM · contact PI

Genomics-based Venom Studies Using the Cone Snail C. Bullatus$283,100

R01 · FY2014 · GM · contact PI

Clinical Genome Inference System: Variant Prioritization for Clinical Diagnostics$781,754

R44 · FY2013 · HG

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding$516,603

R01 · FY2013 · GM · contact PI

Genomics-based Venom Studies Using the Cone Snail C. Bullatus$273,650

R01 · FY2013 · GM · contact PI

Whole genome screen for novel regulators of tissue homeostasis and regeneration$263,134

R01 · FY2013 · GM · contact PI

Clinical Genome Inference System: Variant Prioritization for Clinical Diagnostics$796,314

R44 · FY2012 · HG

Whole genome screen for novel regulators of tissue homeostasis and regeneration$359,307

R01 · FY2012 · GM · contact PI

Genomics-based Venom Studies Using the Cone Snail C. Bullatus$284,050

R01 · FY2012 · GM · contact PI

Clinical Genome Inference System: Variant Prioritization for Clinical Diagnostics$174,360

R44 · FY2012 · HG

Software for the creation and quality control of genome annotations$558,366

R01 · FY2011 · HG · contact PI

Whole genome screen for novel regulators of tissue homeostasis and regeneration$360,553

R01 · FY2011 · GM · contact PI

Software for the creation and quality control of genome annotations$555,744

R01 · FY2010 · HG · contact PI

Tool for annotation and analyses of human whole-genome sequence variation data$384,738

RC2 · FY2010 · HG · contact PI

Whole genome screen for novel regulators of tissue homeostasis and regeneration$296,442

R01 · FY2010 · GM · contact PI

Computational system to predict novel genetic disease associations$262,867

R44 · FY2010 · HG

Computational system to predict novel genetic disease associations$587,913

R44 · FY2009 · HG

Software for the creation and quality control of genome annotations$547,378

R01 · FY2009 · HG · contact PI

Tool for annotation and analyses of human whole-genome sequence variation data$400,000

RC2 · FY2009 · HG · contact PI

Software for the creation and quality control of genome annotations$544,628

R01 · FY2008 · HG · contact PI